Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry
Zilun Li, Meixiu Peng, Pin Chen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 424-440.e7
Open Access | Times Cited: 44

Showing 26-50 of 44 citing articles:

Food-Derived Up-Regulators and Activators of Angiotensin Converting Enzyme 2: A Review
Z. Wang, Hongbing Fan, Jianping Wu
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 23, pp. 12896-12914
Open Access | Times Cited: 1
An analysis combining proteomics and transcriptomics revealed a regulation target of sea cucumber autolysis
Tingting Yan, Jinghe Sun, Jie Zheng, et al.
Comparative Biochemistry and Physiology Part D Genomics and Proteomics (2024) Vol. 52, pp. 101274-101274
Closed Access | Times Cited: 1
ACE2 alleviates sepsis-induced cardiomyopathy through inhibiting M1 macrophage via NF-κB/STAT1 signals
Xue Xiao, Jiaxin Li, Huihua Li, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination
Jie Jiao, Yang Shen, Pan Wang, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 10, pp. 280-280
Open Access | Times Cited: 8
Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease
Arittra Bhattacharjee, Ishtiaque Ahammad, Zeshan Mahmud Chowdhury, et al.
Molecular Biotechnology (2022) Vol. 66, Iss. 4, pp. 626-640
Open Access | Times Cited: 6
Multi-omics analysis of attenuated variant reveals potential evaluation marker of host damaging for SARS-CoV-2 variants
Guangshan Xie, Lin Zhu, Siwen Liu, et al.
Science China Life Sciences (2023)
Closed Access | Times Cited: 3
Butyrate Protects against SARS-CoV-2-Induced Tissue Damage in Golden Hamsters
Huan Yu, Lunzhi Yuan, Zhigang Yan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14191-14191
Open Access | Times Cited: 2
Characterization of dietary and herbal sourced natural compounds that modulate SEL1L-HRD1 ERAD activity and alleviate protein misfolding in the ER
Jifeng Yang, Yaping Zhi, Shiyi Wen, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 111, pp. 109178-109178
Closed Access | Times Cited: 4
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial
Erik Duijvelaar, Xiaoke Pan, Harm Jan Bogaard, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access
Carbonic anhydrase inhibitors prevent presymptomatic capillary flow disturbances in a model of cerebral amyloidosis
Eugenio Gutiérrez‐Jiménez, Peter Mondrup Rasmussen, Irene Klærke Mikkelsen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
CD40LG and GZMB were correlated with adipose tissue macrophage infiltration and involved in obstructive sleep apnea related metabolic dysregulation: Evidence from bioinformatics analysis
Xiaoping Ming, Weisong Cai, Zhen Li, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
A gene expression profile-based approach to screen the occurrence and predisposed host characteristics of drug-induced liver injury: a case study of Psoralea corylifolia Linn
Mingliang Zhang, Weixia Li, Xiaoyan Wang, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 1
Protocol for high-throughput screening of ACE2 enzymatic activators to treat COVID-19-induced metabolic complications
Pin Chen, Chenshu Liu, Zhongyu Zhang, et al.
STAR Protocols (2022) Vol. 3, Iss. 3, pp. 101641-101641
Open Access | Times Cited: 2
Targeting human thymidylate synthase: Ensemble-based virtual screening for drug repositioning and the role of water
Denis Mteremko, Jaffu Chilongola, Andrew S. Paluch, et al.
Journal of Molecular Graphics and Modelling (2022) Vol. 118, pp. 108348-108348
Open Access | Times Cited: 2
Detection, identification, characterization, and high‐performance liquid chromatography quantification of five impurities from a methazolamide product
Qirong Shen, Quan He, Yuanjiang Pan, et al.
Journal of Separation Science (2022) Vol. 45, Iss. 16, pp. 3128-3138
Closed Access | Times Cited: 1
Revisiting potential value of antitumor drugs in the treatment of COVID-19
Wenfang Zheng, Zekun Zeng, Shumei Lin, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Clinically Evaluated COVID-19 Drugs with Therapeutic Potential for Biological Warfare Agents
Ido-David Dechtman, Ran Ankory, Keren Sokolinsky, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1577-1577
Open Access
Epigenetics of SARS-CoV2 (COVID-19)
Sarita Rawat, Ritu Gilhotra, Santosh Kumar Singh, et al.
(2023), pp. 199-208
Closed Access
Targeting Human Thymidylate Synthase: Ensemble-based Virtual Screening for Drug Repositioning and the Role of Water
Denis Mteremko, Jaffu Chilongola, Andrew S. Paluch, et al.
Research Square (Research Square) (2022)
Open Access
ACE2: A Dilemma in Regulating SARS-CoV-2 Infection and its Metabolic Complications
Yan‐Chuan Shi
BIO Integration (2022) Vol. 4, Iss. 1
Open Access
Previous Page - Page 2

Scroll to top